Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Balthaser Kevin
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(2.9%)
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Humphries William D.
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Molineaux Christopher P.
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOWEN MAXINE
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mehra Anand
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SCHIFF ANDREW N
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Humphries William D.
No Data
No Data